Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGPL1 | O95470 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL291993 | 0.84 | TSHR (0.32) | — | |
| SCHEMBL14256306 | 0.83 | — | — | |
| SCHEMBL13935541 | 0.82 | TSHR (0.31) | — | |
| SCHEMBL13935572 | 0.82 | TSHR (0.35) | — | |
| SCHEMBL11759538 | 0.82 | TSHR (0.40) | — | |
| SCHEMBL337324 | 0.81 | PTGS1 (0.31) | — | |
| SCHEMBL5822587 | 0.81 | SMN1; SMN2 (0.36) | — | |
| SCHEMBL29581677 | 0.80 | TSHR (0.39) | — | |
| SCHEMBL216588 | 0.80 | — | — | |
| SCHEMBL127677 | 0.80 | ALDH1A1 (0.34) | SGPL1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-07-31 | — | — | US | disclosed |
| US-7390840-B2 | Active ray curable composition, active ray curable ink, image forming method and inkjet recording apparatus utilizing the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-06-24 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1837357-A1 | ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, METHOD OF IMAGE FORMING THEREWITH, INKJET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | ROCK1, MACF1, ACTN1 | SGPL1 4608/4885S1PR1 3220/4885PIK3CD 1127/4885 |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | SGPL1 4182/4885S1PR1 1167/4885PIK3CD 1902/4885 |
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | RIF1, NAP1L4, NAP1L1 | SGPL1 4194/4885S1PR1 3982/4885PIK3CD 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.